The effect of PD-1/Al@OV on TAM depletion and modulation of the glioma immune microenvironment was analyzed using flow cytometry (FCAS) and immunohistochemistry in GL261 glioma-bearing C57BL/6 mice. The gene discussed is PDCD1; the disease is central nervous system cancer.